Search

Your search keyword '"Chiaretti, A"' showing total 575 results

Search Constraints

Start Over You searched for: Author "Chiaretti, A" Remove constraint Author: "Chiaretti, A" Database Unpaywall Remove constraint Database: Unpaywall
575 results on '"Chiaretti, A"'

Search Results

2. The EV antibody database: An interactive database of curated antibodies for extracellular vesicle and nanoparticle research

6. Comparative study of laparoscopic ventral mesh rectopexy versus perineal stapler resection for external full-thickness rectal prolapse in elderly patients: enhanced outcomes and reduced recurrence rates—a retrospective cohort study

7. A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study

9. Management of ALL in Adults: 2023 ELN Recommendations from a European Expert Panel

10. Diagnosis, Prognostic Factors and Assessment of ALL in Adults: 2023 ELN Recommendations from a European Expert Panel

11. ACUTE LYMPHOBLASTIC LEUKAEMIA OCCURRED 21 YEARS AFTER A FIRST DIAGNOSIS IN A DOWN SYNDROME PATIENT SUCCESFULLY TREATED WITH BLINATUMOMAB

12. The Soils of Nevada

14. Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL

18. Soil-Forming Processes in Nevada

19. Aridisols

21. Entisols

22. Soil-Forming Factors

23. Alfisols, Vertisols, and Andisols

24. History of Soil Studies in Nevada

26. Conclusions

27. Mollisols

28. General Soil Regions of Nevada

29. Land Use in Nevada

30. Soil Geomorphology of Nevada

31. Inceptisols

32. Taxonomic Soil Regions of Nevada

33. Overview

35. BH3 mimetics in relapsed and refractory adult acute lymphoblastic leukemia: a Campus ALL real-life study

36. Intranasal human-recombinant NGF administration improves outcome in children with post-traumatic unresponsive wakefulness syndrome

37. Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study

38. P361: HIGH REMISSION AND SURVIVAL RATE IN ADULTS WITH MINIMAL RESIDUAL DISEASE-POSITIVE OR RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA TREATED WITH BLINATUMOMAB IN ROUTINE CLINICAL PRACTICE

39. PB1711: DROPLET DIGITAL PCR DETECTION OF THE T315I BCR::ABL1 KD MUTATION IN ADULT PH-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA

40. P371: PONATINIB AS A PROPHYLACTIC OR PRE-EMPTIVE STRATEGY TO PREVENT CYTOLOGICAL RELAPSE AFTER ALLO-SCT IN PATIENTS WITH PH POS ALL TRANSPLANTED IN COMPLETE CYTOLOGICAL REMISSION

41. P372: CMV REACTIVATIONS/INFECTIONS IN PH+ ALL PATIENTS TREATED WITH DASATINIB WITH OR WITHOUT BLINATUMOMAB. A RETROSPECTIVE MULTICENTER CAMPUS ALL STUDY

43. Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial

45. Combined treatment of nerve growth factor and transcranical direct current stimulations to improve outcome in children with vegetative state after out-of-hospital cardiac arrest

49. Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia

Catalog

Books, media, physical & digital resources